Aimovig (erenumab) is a once-monthly self-injection for the prevention of migraines. By taking Aimovig, you can reduce the number of migraine-free days each month, allowing you to reclaim your time with friends and family. Aimovig blocks calcitonin gene-related peptide (CGRP) receptors.
In some patients, Aimovig cut the number of average migraine days in half each month. Across a three-month study, people who took Aimovig experienced six to seven fewer chronic migraine days each month compared to less than four fewer each month for the placebo group. Patients also noticed three to four fewer episodic migraines compared to less than two fewer for the placebo group.
Medication type:
Injection, monthly
Recommended for:
✓ Preventing migraine/headache symptoms
✓ Reducing the frequency of migraines
We also charge a $60 medication consultation, which includes unlimited access to our medical team for a full year.